Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Identification and clinical significance of myeloid-derived suppressor cells in peripheral blood of small-cell lung cancer patients].

Zhonghua zhong liu za zhi [Chinese journal of oncology] - 1 Aug 2014

Cheng Ying, Li Hui, Zhao Dandan, Han Qihui, Liu Ying, Liu Xianhong, Ma Lixia, Liu Jingjing

Abstract excerpt

OBJECTIVE: To explore the presence, frequency and clinical value of myeloid-derived suppressor cells (MDSCs) in peripheral blood of patients with small cell lung cancer (SCLC). METHODS: Flow cytometry using antibodies against CD11b, CD33, CD14 or HLA-DR was conducted to explore the unique cell surface markers of MDSCs and statistical analysis was performed to explore the correlation of MDSCs and clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Flow Cytometry
Share to HLA-DR Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Myeloid Cells

Share to Phenotype

Share to Prognosis

Share to Small Cell Lung Carcinoma

Source

Identifiers

PMID: 25430025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Identification and clinical significance of myeloid-derived suppressor cells in peripheral blood of small-cell lung cancer patients].PMID 25430025Read ↗

Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics.Semantic proximity Read ↗

Myeloid‑derived suppressor cell accumulation induces Treg expansion and modulates lung malignancy progressionSemantic proximity Read ↗

MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLCSemantic proximity Read ↗

A novel subset of B7-H3<sup>+</sup>CD14<sup>+</sup>HLA-DR<sup>−/low</sup>myeloid-derived suppressor cells are associated with progression of human NSCLCSemantic proximity Read ↗

Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphomaSemantic proximity Read ↗

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.Semantic proximity Read ↗

The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancerSemantic proximity Read ↗

The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis.Semantic proximity Read ↗

Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.Semantic proximity Read ↗

Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell SubsetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.